However, SIV Gag-specific T cell responses elicited by the ChAd- and MVA-vectored vaccines were of relatively low magnitude, and neither peripheral blood mononuclear cell (PBMC) nor lymph node CD4+ and CD8+ T cell responses at week 14 correlated with the number of challenges to achieve infection or with peak viremia. The gene discussed is CD4; the disease is infection.